These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19382172)

  • 1. Fixing the game: are between-silo differences in funding arrangements handicapping some interventions and giving others a head-start?
    Segal L; Dalziel K; Mortimer D
    Health Econ; 2010 Apr; 19(4):449-65. PubMed ID: 19382172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New payment model for rural health services in Mongolia.
    Hindle D; Khulan B
    Rural Remote Health; 2006; 6(1):434. PubMed ID: 16460229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capitation funding of primary health organisations in New Zealand: are enrolled populations being funded according to need?
    Langton J; Crampton P
    N Z Med J; 2008 Apr; 121(1272):47-58. PubMed ID: 18425154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current funding and financing issues in the Australian hospice and palliative care sector.
    Gordon R; Eagar K; Currow D; Green J
    J Pain Symptom Manage; 2009 Jul; 38(1):68-74. PubMed ID: 19615629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost effectiveness and health sector reform].
    Musgrove P
    Salud Publica Mex; 1995; 37(4):363-74. PubMed ID: 7502159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
    Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
    Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Threshold values for cost-effectiveness ratio and public funding of medical technologies].
    Rabinovich M; Greenberg D; Shemer J
    Harefuah; 2007 Jun; 146(6):453-8, 500. PubMed ID: 17760400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ryan White CARE Act Title IV programs: a preliminary characterization of benefits and costs.
    Abramowitz S; Greene D
    AIDS Public Policy J; 2005; 20(3-4):108-25. PubMed ID: 17624034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimated effectiveness and cost-effectiveness of federally funded prevention efforts on gonorrhea rates in the United States, 1971-2003, under various assumptions about the impact of prevention funding.
    Chesson HW
    Sex Transm Dis; 2006 Oct; 33(10 Suppl):S140-4. PubMed ID: 16505737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cost-effectiveness of rotavirus vaccination in Australia.
    Newall AT; Beutels P; Macartney K; Wood J; MacIntyre CR
    Vaccine; 2007 Dec; 25(52):8851-60. PubMed ID: 18022735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current costing models: are they suitable for allocating health resources? The example of fall injury prevention in Australia.
    Moller J
    Accid Anal Prev; 2005 Jan; 37(1):25-33. PubMed ID: 15607272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of cost, rates, and staffing by provider and client characteristics.
    Campbell EM; Heal LW
    Am J Ment Retard; 1995 Jul; 100(1):17-35. PubMed ID: 7546634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk-adjusted capitation funding models for chronic disease in Australia: alternatives to casemix funding.
    Antioch KM; Walsh MK
    Eur J Health Econ; 2002; 3(2):83-93. PubMed ID: 15609134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A successful practical application of Coverage with Evidence Development in Australia: Medical Services Advisory Committee interim funding and the PillCam Capsule Endoscopy Register.
    O'Malley SP; Selby WS; Jordan E
    Int J Technol Assess Health Care; 2009 Jul; 25(3):290-6. PubMed ID: 19619347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
    Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
    J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in outpatient mental health service utilization under capitation.
    Chou AF; Wallace N; Bloom JR; Hu TW
    J Ment Health Policy Econ; 2005 Mar; 8(1):3-14. PubMed ID: 15870481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why and how to invest in neonatal health.
    Mangiaterra V; Mattero M; Dunkelberg E
    Semin Fetal Neonatal Med; 2006 Feb; 11(1):37-47. PubMed ID: 16414318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.